Intrinsic Value

Aeglea BioTherapeutics, Inc. (AGLE)

$12.01

+0.75 (+6.66%)

Enterprise Value -
Net Debt -30.23
Equity Value -
Shares Outstanding 3.37
Equity Value Per Share -



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt